Prognostic Impact of Sarcopenia’s Occurrence during Radiotherapy in Oropharyngeal Cancer Patients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The current study aims to profile sarcopenic condition (both at baseline and developed during treatment) in oropharyngeal carcinoma (OPC) patients treated with curative radiotherapy (RT) +/− chemotherapy and to evaluate its impact on oncological outcomes and toxicity. A total of 116 patients were included in this retrospective single-center study. Sarcopenia assessment at baseline and at 50 Gy re-evaluation CT was obtained from two different methodologies: (i) the L3-skeletal muscle index (SMI) derived from the contouring of the cross-sectional area (CSA) of the masticatory muscles (CSA-MM); and (ii) the paravertebral and sternocleidomastoid muscles at the level of the third cervical vertebra (CSA-C3). Based on L3-SMI from CSA-MM, developing sarcopenic condition during RT (on-RT sarcopenia) was associated with worse progression-free survival (PFS) (p = 0.03) on multivariable analysis and a trend of correlation with overall survival (OS) was also evident (p = 0.05). According to L3-SMI derived from CSA-C3, on-RT sarcopenia was associated with worse PFS (p = 0.0096) and OS (p = 0.013) on univariate analysis; these associations were not confirmed on multivariable analysis. A significant association was reported between becoming on-RT sarcopenia and low baseline haemoglobin (p = 0.03) and the activation of nutritional counselling (p = 0.02). No significant associations were found between sarcopenia and worse RT toxicity. Our data suggest that the implementation of prompt nutritional support to prevent the onset of sarcopenia during RT could improve oncological outcomes in OPC setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Research works printed but not linked: 67
- Lechner, 2022, HPV-Associated Oropharyngeal Cancer: Epidemiology, Molecular Biology and Clinical Management, Nat. Rev. Clin. Oncol., 19, 306, 10.1038/s41571-022-00603-7 · DOI · Paper page
- Ang, 2010, Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, N. Engl. J. Med., 363, 24, 10.1056/NEJMoa0912217 · DOI · Paper page
- Habbous, 2014, Comorbidity and Prognosis in Head and Neck Cancers: Differences by Subsite, Stage, and Human Papillomavirus Status, Head Neck, 36, 802, 10.1002/hed.23360 · DOI
- Pytynia, 2014, Epidemiology of HPV-Associated Oropharyngeal Cancer, Oral Oncol., 50, 380, 10.1016/j.oraloncology.2013.12.019 · doi:10.1016/j.oraloncology.2013.12.019
- Van Gysen, K., Stevens, M., Guo, L., Jayamanne, D., Veivers, D., Wignall, A., Pang, L., Guminski, A., Lee, A., and Hruby, G. (2019). Validation of the 8th Edition UICC/AJCC TNM Staging System for HPV Associated Oropharyngeal Cancer Patients Managed with Contemporary Chemo-Radiotherapy. BMC Cancer, 19. · doi:10.1186/s12885-019-5894-8
- Cavalieri, 2022, Which Future for De-Intensified Treatments in HPV-Related Oropharyngeal Carcinoma?, Semin. Oncol., 49, 405, 10.1053/j.seminoncol.2022.09.007 · doi:10.1053/j.seminoncol.2022.09.007
- Costantino, 2020, Present and Future of De-Intensification Strategies in the Treatment of Oropharyngeal Carcinoma, Curr. Oncol. Rep., 22, 91, 10.1007/s11912-020-00948-1 · doi:10.1007/s11912-020-00948-1
- Mehanna, 2020, De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies, J. Clin. Oncol., 38, 2552, 10.1200/JCO.20.00056 · doi:10.1200/jco.20.00056
- Strohl, 2020, De-Intensification Strategies in HPV-Related Oropharyngeal Squamous Cell Carcinoma-a Narrative Review, Ann. Transl. Med., 8, 1601, 10.21037/atm-20-2984 · doi:10.21037/atm-20-2984
- Sung, S.-Y., Kim, Y.-S., Kim, S.H., Lee, S.J., Lee, S.-W., and Kwak, Y.-K. (2022). Current Evidence of a Deintensification Strategy for Patients with HPV-Related Oropharyngeal Cancer. Cancers, 14. · doi:10.3390/cancers14163969
- Mazurak, 2016, Computed Tomography-Defined Muscle and Fat Wasting Are Associated with Cancer Clinical Outcomes, Semin. Cell Dev. Biol., 54, 2, 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
- Shachar, 2016, Prognostic Value of Sarcopenia in Adults with Solid Tumours: A Meta-Analysis and Systematic Review, Eur. J. Cancer, 57, 58, 10.1016/j.ejca.2015.12.030 · DOI · Paper page
- Fearon, 2011, Definition and Classification of Cancer Cachexia: An International Consensus, Lancet Oncol., 12, 489, 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- Cho, 2018, Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy, Front. Oncol., 8, 457, 10.3389/fonc.2018.00457 · DOI
- Findlay, 2021, Is Sarcopenia a Predictor of Prognosis for Patients Undergoing Radiotherapy for Head and Neck Cancer? A Meta-Analysis, Clin. Nutr., 40, 1711, 10.1016/j.clnu.2020.09.017 · DOI
- Wendrich, 2017, Low Skeletal Muscle Mass Is a Predictive Factor for Chemotherapy Dose-Limiting Toxicity in Patients with Locally Advanced Head and Neck Cancer, Oral Oncol., 71, 26, 10.1016/j.oraloncology.2017.05.012 · DOI · Paper page
- Zwart, 2019, CT-Measured Skeletal Muscle Mass Used to Assess Frailty in Patients with Head and Neck Cancer, J. Cachexia Sarcopenia Muscle, 10, 1060, 10.1002/jcsm.12443 · DOI
- Borges, 2021, High Neutrophil to Lymphocytes Ratio Is Associated with Sarcopenia Risk in Hospitalized Cancer Patients, Clin. Nutr., 40, 202, 10.1016/j.clnu.2020.05.005 · DOI
- Fanetti, 2020, Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in HPV Status Era for Oropharyngeal Cancer, Oral Dis., 26, 1384, 10.1111/odi.13366 · DOI
- Feliciano, 2017, Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study, JAMA Oncol., 3, e172319, 10.1001/jamaoncol.2017.2319 · DOI · Paper page
- Lin, 2018, Sarcopenia Is Associated with the Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios in Operable Gastric Cancer Patients: A Prospective Study, Cancer Manag. Res., 10, 4935, 10.2147/CMAR.S175421 · DOI
- Kul, 2018, Is Increased Neutrophil Lymphocyte Ratio Remarking the Inflammation in Sarcopenia?, Exp. Gerontol., 110, 223, 10.1016/j.exger.2018.06.013 · DOI
- Zhang, 2016, Incidence and Risk Factor Analysis for Sarcopenia in Patients with Cancer, Oncol. Lett., 11, 1230, 10.3892/ol.2015.4019 · DOI
- Ganju, 2019, The Impact of Sarcopenia on Tolerance of Radiation and Outcome in Patients with Head and Neck Cancer Receiving Chemoradiation, Radiother. Oncol., 137, 117, 10.1016/j.radonc.2019.04.023 · DOI
- Grossberg, 2016, Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma, JAMA Oncol., 2, 782, 10.1001/jamaoncol.2015.6339 · DOI · Paper page
- Dijkstra, 2017, High Prevalence of Cachexia in Newly Diagnosed Head and Neck Cancer Patients: An Exploratory Study, Nutrition, 35, 114, 10.1016/j.nut.2016.11.008 · DOI
- Nishikawa, 2018, The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma, ORL J. Otorhinolaryngol. Relat. Spec., 80, 1, 10.1159/000485515 · DOI
- Bijl, 2020, Impact of Sarcopenia on Survival and Late Toxicity in Head and Neck Cancer Patients Treated with Radiotherapy, Radiother. Oncol., 147, 103, 10.1016/j.radonc.2020.03.014 · DOI
- Willemsen, 2020, Disease-Induced and Treatment-Induced Alterations in Body Composition in Locally Advanced Head and Neck Squamous Cell Carcinoma, J. Cachexia Sarcopenia Muscle, 11, 145, 10.1002/jcsm.12487 · DOI
- Arribas, 2017, Nutritional Changes in Patients with Locally Advanced Head and Neck Cancer during Treatment, Oral Oncol., 71, 67, 10.1016/j.oraloncology.2017.06.003 · DOI
- Langendijk, 2008, Impact of Late Treatment-Related Toxicity on Quality of Life among Patients with Head and Neck Cancer Treated with Radiotherapy, J. Clin. Oncol., 26, 3770, 10.1200/JCO.2007.14.6647 · DOI · Paper page
- Sroussi, 2017, Common Oral Complications of Head and Neck Cancer Radiation Therapy: Mucositis, Infections, Saliva Change, Fibrosis, Sensory Dysfunctions, Dental Caries, Periodontal Disease, and Osteoradionecrosis, Cancer Med., 6, 2918, 10.1002/cam4.1221 · DOI · Paper page
- Swartz, 2016, Feasibility of Using Head and Neck CT Imaging to Assess Skeletal Muscle Mass in Head and Neck Cancer Patients, Oral Oncol., 62, 28, 10.1016/j.oraloncology.2016.09.006 · DOI · Paper page
- Bril, 2019, Interobserver Agreement of Skeletal Muscle Mass Measurement on Head and Neck CT Imaging at the Level of the Third Cervical Vertebra, Eur. Arch. Otorhinolaryngol., 276, 1175, 10.1007/s00405-019-05307-w · DOI
- Bril, 2021, Validation of Skeletal Muscle Mass Assessment at the Level of the Third Cervical Vertebra in Patients with Head and Neck Cancer, Oral Oncol., 123, 105617, 10.1016/j.oraloncology.2021.105617 · DOI
- Meerkerk, 2022, Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty, Front. Oncol., 12, 884988, 10.3389/fonc.2022.884988 · DOI
- Ufuk, 2019, Diagnosis of Sarcopenia in Head and Neck Computed Tomography: Cervical Muscle Mass as a Strong Indicator of Sarcopenia, Clin. Exp. Otorhinolaryngol., 12, 317, 10.21053/ceo.2018.01613 · DOI
- Chang, S.-W., Tsai, Y.-H., Hsu, C.-M., Huang, E.I., Chang, G.-H., Tsai, M.-S., and Tsai, Y.-T. (2021). Masticatory Muscle Index for Indicating Skeletal Muscle Mass in Patients with Head and Neck Cancer. PLoS ONE, 16. · DOI
- Vermorken, 2008, Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer, N. Engl. J. Med., 359, 1116, 10.1056/NEJMoa0802656 · DOI · Paper page
- Szturz, 2017, Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data, Oncologist, 22, 1056, 10.1634/theoncologist.2017-0015 · DOI · Paper page
- Aguiar, 2016, Definitive Chemoradiotherapy for Squamous Head and Neck Cancer: Cisplatin versus Carboplatin? A Meta-Analysis, Future Oncol., 12, 2755, 10.2217/fon-2016-0068 · doi:10.2217/fon-2016-0068
- Bonner, 2006, Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck, N. Engl. J. Med., 354, 567, 10.1056/NEJMoa053422 · DOI · Paper page
- Prado, 2008, Prevalence and Clinical Implications of Sarcopenic Obesity in Patients with Solid Tumours of the Respiratory and Gastrointestinal Tracts: A Population-Based Study, Lancet Oncol., 9, 629, 10.1016/S1470-2045(08)70153-0 · DOI · Paper page
- Medici, 2022, Everything You Always Wanted to Know about Sarcopenia but Were Afraid to Ask: A Quick Guide for Radiation Oncologists (Impact of Sarcopenia in Radiotherapy: The AFRAID Project), Curr. Oncol., 29, 8513, 10.3390/curroncol29110671 · DOI · Paper page
- Findlay, 2020, The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review, J. Acad. Nutr. Diet., 120, 1330, 10.1016/j.jand.2020.03.021 · DOI
- Yoon, J.-K., Jang, J.Y., An, Y.-S., and Lee, S.J. (2021). Skeletal Muscle Mass at C3 May Not Be a Strong Predictor for Skeletal Muscle Mass at L3 in Sarcopenic Patients with Head and Neck Cancer. PLoS ONE, 16. · DOI
- Jin, 2022, A Single Axial Slice of the Sternocleidomastoids and Paravertebral Muscles Associated with Worse Local Progression-Free Survival and Severe Toxicity in Sarcopenic Head and Neck Cancer Patients Undergoing Radiotherapy, Cureus, 14, e22463
- Karavolia, 2022, Impact of Sarcopenia on Acute Radiation-Induced Toxicity in Head and Neck Cancer Patients, Radiother. Oncol., 170, 122, 10.1016/j.radonc.2022.03.009 · DOI
- Nagpal, 2021, Impact of Sarcopenia in Locally Advanced Head and Neck Cancer Treated with Chemoradiation: An Indian Tertiary Care Hospital Experience, Oral Oncol., 121, 105483, 10.1016/j.oraloncology.2021.105483 · DOI
- Shodo, 2021, Sarcopenia Predicts a Poor Treatment Outcome in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy, Eur. Arch. Otorhinolaryngol., 278, 2001, 10.1007/s00405-020-06273-4 · DOI
- Thureau, S., Lebret, L., Lequesne, J., Cabourg, M., Dandoy, S., Gouley, C., Lefebvre, L., Mallet, R., Mihailescu, S.-D., and Moldovan, C. (2021). Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy. Cancers, 13. · DOI
- Edwards, 2022, The Changing Face of Head and Neck Cancer: Are Patients with Human Papillomavirus-Positive Disease at Greater Nutritional Risk? A Systematic Review, Support Care Cancer, 30, 7191, 10.1007/s00520-022-07056-9 · DOI
- Olson, 2020, Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients with Localized Oropharyngeal Squamous Cell Carcinoma, JAMA Otolaryngol. Head Neck Surg., 146, 714, 10.1001/jamaoto.2020.1154 · DOI
- Volpe, 2018, Nutritional Intervention for Nonsurgical Head and Neck Cancer Patients Treated with Radiation Therapy: Results from a Prospective Stepped-Wedge Clinical Protocol, Nutr. Cancer, 70, 1051, 10.1080/01635581.2018.1497187 · DOI
- Bye, A., Sandmael, J.A., Stene, G.B., Thorsen, L., Balstad, T.R., Solheim, T.S., Pripp, A.H., and Oldervoll, L.M. (2020). Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-Analysis. Nutrients, 12. · DOI
- Prado, 2020, Nutrition Interventions to Treat Low Muscle Mass in Cancer, J. Cachexia Sarcopenia Muscle, 11, 366, 10.1002/jcsm.12525 · DOI · Paper page
- Schaeffers, 2022, Sarcopenia and Its Impact in Head and Neck Cancer Treatment, Curr. Opin. Otolaryngol. Head Neck Surg., 30, 87, 10.1097/MOO.0000000000000792 · DOI
- Vangelov, 2022, The Effectiveness of Skeletal Muscle Evaluation at the Third Cervical Vertebral Level for Computed Tomography-Defined Sarcopenia Assessment in Patients with Head and Neck Cancer, Head Neck, 44, 1047, 10.1002/hed.27000 · DOI
- Yang, 2022, Significant Muscle Loss after Stereotactic Body Radiotherapy Predicts Worse Survival in Patients with Hepatocellular Carcinoma, Sci. Rep., 12, 19100, 10.1038/s41598-022-21443-6 · DOI · Paper page
- Lee, 2018, Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer, Clin. Cancer Res., 24, 5028, 10.1158/1078-0432.CCR-18-0788 · DOI
- Lee, 2019, Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy, Front. Oncol., 9, 1075, 10.3389/fonc.2019.01075 · DOI
- Hoff, 2012, Importance of Hemoglobin Concentration and Its Modification for the Outcome of Head and Neck Cancer Patients Treated with Radiotherapy, Acta Oncol., 51, 419, 10.3109/0284186X.2011.653438 · DOI
- Gunn, 2021, Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience, Int. J. Part Ther., 8, 108, 10.14338/IJPT-20-00065.1 · doi:10.14338/ijpt-20-00065.1
- Gamez, 2021, Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer, Int. J. Part Ther., 8, 223, 10.14338/IJPT-20-00073.1 · doi:10.14338/ijpt-20-00073.1
- Zwart, A.T., Pörtzgen, W., van Rijn-Dekker, I., Sidorenkov, G.A., Dierckx, R.A.J.O., Steenbakkers, R.J.H.M., Wegner, I., van der Hoorn, A., de Bock, G.H., and Halmos, G.B. (2022). Sex-Specific Cut-Off Values for Low Skeletal Muscle Mass to Identify Patients at Risk for Treatment-Related Adverse Events in Head and Neck Cancer. J. Clin. Med., 11. · DOI
- Britton, 2019, Eating As Treatment (EAT): A Stepped-Wedge, Randomized Controlled Trial of a Health Behavior Change Intervention Provided by Dietitians to Improve Nutrition in Patients With Head and Neck Cancer Undergoing Radiation Therapy (TROG 12.03), Int. J. Radiat. Oncol. Biol. Phys., 103, 353, 10.1016/j.ijrobp.2018.09.027 · DOI
- Lonkvist, 2017, Progressive Resistance Training in Head and Neck Cancer Patients Undergoing Concomitant Chemoradiotherapy, Laryngoscope Investig. Otolaryngol., 2, 295, 10.1002/lio2.88 · DOI
Cited by
Vickers, A. J., McSweeney, D. M., Choudhury, A., Weaver, J., West, C., Kerns, S., Azria, D., Farcy-Jaquet, M.-P., Chang-Claude, J., Dunning, A., et al. (2026) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2026.111673
Metadata
- Authors
- Bergamaschi, L., Marvaso, G., Zaffaroni, M., Vincini, M. G., D’Ecclesiis, O., Volpe, S., Ferrari, A., Zorzi, S. F., Rocca, M. C., Sabbatini, A., Cannillo, G., Zagallo, E., Starzyńska, A., Ansarin, M., Cattani, F., Gandini, S., Orecchia, R., Alterio, D., & Jereczek-Fossa, B. A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-01-24
- Volume
- 15
- Issue
- 3
- Pages
- 723
- ISSN
- 2072-6694
- Cited by
- 12
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.